Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
866 studies found for:    Open Studies | "Prostatic Neoplasms"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Prostatic Neoplasms"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Irreversible Electroporation(IRE) For Unresectable Prostatic Neoplasms
Condition: Prostatic Neoplasms
Interventions: Procedure: Irreversible electroporation (IRE);   Device: NanoKnife
2 Recruiting A Registry of Participants With Prostate Cancer in Asia
Condition: Prostatic Neoplasms
Intervention: Other: No Intervention
3 Recruiting Enzalutamide in Androgen Deprivation Therapy With Radiation Therapy for High Risk, Clinically Localised, Prostate Cancer
Condition: Prostatic Neoplasms
Interventions: Drug: Enzalutamide;   Drug: Conventional NSAA;   Drug: LHRHA;   Radiation: External Beam Radiotherapy (78 Gy in 39 fractions or 46 Gy in 23 fractions plus brachytherapy boost)
4 Recruiting Collection of Blood From Patients With Prostate Cancer
Condition: Prostatic Neoplasms
Intervention:
5 Recruiting Gallium-68 Citrate PET Used in Prostate Cancer
Condition: Prostatic Neoplasms
Intervention: Procedure: Gallium-68 citrate PET
6 Not yet recruiting Functional MR-guided Stereotactic Body Radiation Therapy of Prostate Cancer
Condition: Prostatic Neoplasms
Intervention: Radiation: Stereotactic body RT with MR-guided boost
7 Recruiting Enzalutamide in First Line Androgen Deprivation Therapy for Metastatic Prostate Cancer
Condition: Prostatic Neoplasms
Interventions: Drug: Enzalutamide;   Drug: NSAA;   Drug: LHRHA or Surgical Castration
8 Recruiting Hormone Therapy Plus Chemotherapy as Initial Treatment for Local Failures or Advanced Prostate Cancer
Condition: Prostatic Neoplasms
Interventions: Drug: Doxorubicin;   Drug: Ketoconazole;   Drug: Docetaxel;   Drug: Estramustine;   Drug: Degarelix
9 Not yet recruiting Detection of High Grade Prostate Cancer With Subharmonic Ultrasound Imaging, A Pilot Study
Condition: Prostatic Neoplasm
Intervention: Drug: Perflutren Lipid Microsphere Intravenous Suspension
10 Recruiting Surgery Versus Radiotherapy for Locally Advanced Prostate Cancer
Condition: Prostatic Neoplasms
Interventions: Procedure: Prostatectomy/Surgery;   Other: Radiotherapy with adjuvant androgen deprivation therapy
11 Recruiting Drug Use Investigation of Xofigo, Castration Resistant Prostate Cancer With Bone Metastases
Condition: Prostatic Neoplasms, Castration-Resistant
Intervention: Drug: Radium-223 dichloride (Xofigo, BAY 88-8223)
12 Recruiting ODM-201 in Addition to Standard ADT and Docetaxel in Metastatic Castration Sensitive Prostate Cancer
Condition: Prostatic Neoplasms
Interventions: Drug: BAY 1841788 / ODM-201;   Drug: Standard ADT (androgen deprivation therapy);   Drug: Docetaxel;   Drug: Placebo
13 Not yet recruiting Single Fraction HDR Brachytherapy Plus Hypofractionated EBRT for Low-risk Prostate Cancer: Phase II Trial
Condition: Prostatic Neoplasms
Intervention: Radiation: HDR brachytherapy + hypofractionated EBRT
14 Recruiting A Study to Evaluate the Effect of Multiple Doses of JNJ-56021927 on the Pharmacokinetics of Multiple Cytochrome P450 and Transporter Substrates in Participants With Castration-Resistant Prostate Cancer
Condition: Prostatic Neoplasms, Castration-Resistant
Interventions: Drug: JNJ 56021927;   Drug: Drug Cocktail;   Drug: Pioglitazone;   Drug: Rosuvastatin
15 Recruiting First-in-man Dose Escalation Study of BAY2010112 in Patients With Prostate Cancer
Condition: Prostatic Neoplasms
Intervention: Biological: BAY2010112
16 Recruiting An Efficacy and Safety Study of JNJ-56021927 (ARN-509) in High-risk Prostate Cancer Subjects Receiving Primary Radiation Therapy: ATLAS
Condition: Prostatic Neoplasms
Interventions: Drug: JNJ-56021927;   Drug: Bicalutamide;   Drug: Bicalutamide Placebo;   Drug: JNJ-56021927 Placebo;   Drug: GnRH (agonist);   Radiation: 74-80 Grays (units of radiation)
17 Recruiting Institut Paoli Calmettes Prostate Cancer Database
Condition: Prostatic Neoplasms
Intervention: Other: Data collection
18 Recruiting Study of Pembrolizumab (MK-3475) Combination Therapies in Metastatic Castration-Resistant Prostate Cancer (MK-3475-365/KEYNOTE-365)
Condition: Prostatic Neoplasms
Interventions: Biological: Pembrolizumab 200 mg;   Drug: Olaparib 400 mg;   Drug: Docetaxel 75 mg/m^2;   Drug: Prednisone 5 mg;   Drug: Enzalutamide 160 mg;   Other: Dexamethasone 8 mg
19 Recruiting A Canadian Observational Study in Metastatic Cancer of the Prostate: A Study of ZYTIGA Use in the Community Urology Setting
Condition: Prostatic Neoplasms
Intervention: Other: Abiraterone Acetate (ZYTIGA): Prostate Cancer Registry
20 Recruiting Stereotactic Radiotherapy for Oligometastatic Prostate Cancer
Condition: Prostatic Neoplasms
Intervention: Radiation: stereotactic radiotherapy

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.